AVITA Medical to Host Investor Webinar Briefing
August 08, 2024 19:00 ET
|
AVITA Medical
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on August 13, 2024.
AVITA Medical Reports Second Quarter Financial Results
August 08, 2024 16:04 ET
|
AVITA Medical
AVITA Medical today reported second-quarter commercial revenue of $15.1 million, reflecting growth of over 29% over the same period in the prior year.
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
August 01, 2024 16:05 ET
|
AVITA Medical
AVITA Medical announces industry leader, Robin VanDenburgh, has joined as Senior Vice President of U.S. Commercial Sales, effective August 6, 2024.
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
July 31, 2024 16:05 ET
|
AVITA Medical
AVITA Medical expands portfolio with unique collagen dermal matrix through an exclusive development and distribution agreement with Regenity Biosciences.
AVITA Medical to Announce Second Quarter 2024 Financial Results
July 11, 2024 16:10 ET
|
AVITA Medical
AVITA Medical will report its second quarter 2024 financial results after market close on August 8 2024 and host a webcast that day at 1:30 PM PDT.
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
July 01, 2024 16:05 ET
|
AVITA Medical
AVITA Medical appoints Nicole Kelsey as Chief Legal and Compliance Officer and Corporate Secretary, succeeding Donna Shiroma who is retiring as GC.
AVITA Medical Achieves Milestone with First Case Using RECELL GO
June 05, 2024 16:25 ET
|
AVITA Medical
Joseph M. Still Burn Center at Doctors Hospital of Augusta treats first patient using AVITA Medical’s FDA-Approved RECELL GO System.
AVITA Medical Announces FDA Approval of RECELL GO
May 30, 2024 09:15 ET
|
AVITA Medical
AVITA Medical receives FDA approval for RECELL GO, its next-generation device used to treat thermal burn wounds and full thickness skin defects.
AVITA Medical to Host Investor Webinar Briefing
May 16, 2024 18:30 ET
|
AVITA Medical
AVITA Medical to host investor webinar briefing and presentation on May 21, 2024, at 4:00 p.m. Pacific Daylight Time.
AVITA Medical Reports First Quarter Financial Results
May 13, 2024 16:01 ET
|
AVITA Medical
AVITA Medical (NASDAQ: RCEL, ASX: AVH) today reported financial results for the first quarter ended March 31, 2024.